ACUMEN PHARMACEUTICALS INC (ABOS) Top Institutional Shareholders

ACUMEN PHARMACEUTICALS INC (ABOS) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $106.38M in ABOS holdings during the latest filing period.

Ra Capital Management, L.P. is currently the largest disclosed institutional shareholder of ABOS tracked by InsiderSet, reporting ownership valued at approximately $49.54M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $47.23M, representing an estimated loss of -4.66% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 84% of the total disclosed ABOS value among the investors covered in this analysis. Major shareholders include Ra Capital Management, L.P., Sands Capital Alternatives, Llc, Alyeska Investment Group, L.P., and several other long-term asset managers with concentrated positions in ACUMEN PHARMACEUTICALS INC (ABOS).

This page ranks the largest institutional ABOS shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

83

Total Reported Value

$106.38M

Largest Holder

Ra Capital Management, L.P.

Largest Position

$49.54M

Insider Transactions (90d)

0

Latest Filing Quarter

Q1 2026

New Institutional Positions

92

Funds Exiting Positions

0

Page 1 of 2
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Ra Capital Management, L.P.0.52%20,992,669$49,542,699$47,233,505-$2,309,194-4.66%
Sands Capital Alternatives, Llc2.08%3,720,105$8,779,448$8,370,236-$409,212-4.66%
Alyeska Investment Group, L.P.0.02%2,454,754$5,776,765$5,523,197-$253,569-4.39%
Franklin Resources Inc0.00%2,305,096$5,440,027$5,186,466-$253,561-4.66%
Adar1 Capital Management, Llc0.31%2,156,334$5,088,948$4,851,752-$237,197-4.66%
Knollwood Investment Advisory, Llc0.39%1,628,510$3,843,284$3,664,148-$179,137-4.66%
Vanguard Capital Management Llc0.00%1,506,277$3,554,814$3,389,123-$165,691-4.66%
Fmr Llc0.00%1,157,346$2,731,337$2,604,029-$127,309-4.66%
Ikarian Capital, Llc0.36%1,053,797$2,486,960$2,371,043-$115,917-4.66%
Hudson Bay Capital Management Lp0.01%968,940$2,286,698$2,180,115-$106,583-4.66%
Pathstone Holdings, Llc0.01%859,110$2,027,500$1,932,998-$94,503-4.66%
Millennium Management Llc0.00%659,675$1,556,833$1,484,269-$72,564-4.66%
Susquehanna International Group, Llp0.00%601,476$1,419,483$1,353,321-$66,162-4.66%
Two Sigma Investments, Lp0.00%530,812$1,252,716$1,194,327-$58,389-4.66%
Laurion Capital Management Lp0.12%525,444$1,240,048$1,182,249-$57,799-4.66%
Renaissance Technologies LLCJim Simons0.00%473,946$1,118,513$1,066,379-$52,135-4.66%
Geode Capital Management, Llc0.00%416,238$982,755$936,536-$46,220-4.70%
Bank Of America Corp0.00%320,216$755,710$720,486-$35,224-4.66%
Boothbay Fund Management, Llc0.01%273,012$644,308$614,277-$30,031-4.66%
Goldman Sachs Group Inc0.00%206,683$487,772$465,037-$22,735-4.66%
Vanguard Fiduciary Trust Co0.00%199,226$470,173$448,259-$21,915-4.66%
Marshall Wace, Llp0.00%192,889$455,218$434,000-$21,218-4.66%
Blackrock, Inc.0.00%178,326$420,849$401,234-$19,616-4.66%
Bridgeway Capital Management, Llc0.01%176,171$415,764$396,385-$19,379-4.66%
State Street Corp0.00%151,728$358,078$341,388-$16,690-4.66%
Morgan Stanley0.00%144,584$341,219$325,314-$15,905-4.66%
Qube Research & Technologies Ltd0.00%120,388$284,116$270,873-$13,243-4.66%
Dimensional Fund Advisors Lp0.00%119,756$281,763$269,451-$12,312-4.37%
Catalyst Financial Partners Llc0.02%89,699$211,690$201,823-$9,867-4.66%
Jane Street Group, Llc0.00%89,661$211,599$201,737-$9,862-4.66%
Pfg Investments, Llc0.01%80,850$190,806$181,913-$8,894-4.66%
Northern Trust Corp0.00%75,212$177,500$169,227-$8,273-4.66%
Point72 Asset Management, L.P.0.00%67,375$159,005$151,594-$7,411-4.66%
Prospera Financial Services Inc0.00%50,000$118,000$112,500-$5,500-4.66%
Catalyst Funds Management Pty Ltd0.02%45,600$107,616$102,600-$5,016-4.66%
Verdad Advisers, Lp0.10%37,278$87,976$83,876-$4,101-4.66%
Ubs Group Ag0.00%37,146$87,665$83,579-$4,087-4.66%
Rangeley Capital, Llc0.09%35,000$82,600$78,750-$3,850-4.66%
Barclays Plc0.00%30,679$72,402$69,028-$3,374-4.66%
Intrepid Financial Planning Group Llc0.03%30,150$71,154$67,838-$3,317-4.66%
Omers Administration Corp0.00%28,600$67,496$64,350-$3,146-4.66%
Axq Capital, Lp0.01%28,487$67,229$64,096-$3,133-4.66%
Independent Advisor Alliance0.00%19,000$44,840$42,750-$2,090-4.66%
Pinnacle Associates Ltd0.00%18,020$42,527$40,545-$1,982-4.66%
Pinnacle Wealth Management Advisory Group, Llc0.00%18,020$42,527$40,545-$1,982-4.66%
American Century Companies Inc0.00%17,929$42,312$40,340-$1,972-4.66%
Simplex Trading, Llc0.00%17,414$41,097$39,182-$1,916-4.66%
Factor Wealth Management Ltd0.01%16,500$38,940$37,125-$1,815-4.66%
Captrust Financial Advisors0.00%15,757$37,187$35,453-$1,734-4.66%
Brevan Howard Capital Management Lp0.00%15,385$36,309$34,616-$1,693-4.66%

Frequently asked questions about ABOS

  • Who owns the most ABOS stock?

    The largest holders of ABOS are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ACUMEN PHARMACEUTICALS INC (ABOS).

  • Is ABOS widely held by superinvestors?

    Many widely followed stocks like ABOS appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly ABOS is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.